Grantham, Mayo, Van Otterloo & Co (GMO)’s Leidos LDOS Stock Holding History
Bought
Maintained
Sold
Other funds holding LDOS
Grantham, Mayo, Van Otterloo & Co (GMO)'s LDOS Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Leidos (LDOS) stake by 89% in Q2 2026, buying an estimated $3.65M and bringing the position to 58,513 shares worth $6.03M. The position accounts for 0.01% of the portfolio, ranked #306.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LDOS in Q4 2013 and has held it in 24 quarters since. The position peaked at $20.3M in Q2 2021. 767 funds tracked by Wall St. Rank hold LDOS as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 58,513 shares of Leidos worth $6.03M as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 27,491 Leidos shares in Q2 2026, an estimated $3.65M.
- Leidos made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #306 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Leidos in Q4 2013 and has held it in 24 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Leidos position peaked at $20.3M in Q2 2021.
- 767 funds tracked by Wall St. Rank held Leidos as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.